AS

Anmol Srivastava

Director Director DIN 08423738
DIN 08423738 First appointment Mar 2019 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Mar 2019
Shareholding value Locked Premium profile

About Anmol Srivastava

Data last updated:

Anmol Srivastava has 7 years in corporate governance. Formerly with 1 company, such as Synokem Pharmaceuticals Limited. Engaged in General Business. Contributes to corporate operations.

DIN 08423738
Primary Designation Director
First Appointment 20 Mar 2019
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
Synokem Pharmaceuticals Limited U21002DL1983PLC016353
Director20 Mar 20191983Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Synokem Pharmaceuticals Limited
Premium access

Shareholding and investment profile for Anmol Srivastava

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Anmol Srivastava

Anmol Srivastava has 7 years in corporate governance. Formerly with 1 company, such as Synokem Pharmaceuticals Limited. Engaged in General Business. Contributes to corporate operations.

Anmol Srivastava is associated with 0 companies as a director.

Anmol Srivastava has expertise in General Business.

Anmol Srivastava has 7 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available